These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22844781)

  • 1. [Effect of topical 0.1% brimonidine tartrate and 0.5% timolol maleate on pulmonary and cardiovascular functions].
    Araie M; Adachi M
    Nippon Ganka Gakkai Zasshi; 2012 Jul; 116(7):623-34. PubMed ID: 22844781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of timolol maleate, brimonidine or brimonidine/timolol maleate in concomitant therapy.
    Stewart WC; Stewart JA; Jackson AL
    Acta Ophthalmol Scand; 2002 Jun; 80(3):277-81. PubMed ID: 12059866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for visual field progression in the low-pressure glaucoma treatment study.
    De Moraes CG; Liebmann JM; Greenfield DS; Gardiner SK; Ritch R; Krupin T;
    Am J Ophthalmol; 2012 Oct; 154(4):702-11. PubMed ID: 22835512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine.
    Nordlund JR; Pasquale LR; Robin AL; Rudikoff MT; Ordman J; Chen KS; Walt J
    Arch Ophthalmol; 1995 Jan; 113(1):77-83. PubMed ID: 7826297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
    J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study.
    Krupin T; Liebmann JM; Greenfield DS; Ritch R; Gardiner S;
    Am J Ophthalmol; 2011 Apr; 151(4):671-81. PubMed ID: 21257146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ulcerated infantile hemangioma: novel treatment with topical brimonidine-timolol.
    Beal BT; Chu MB; Siegfried EC
    Pediatr Dermatol; 2014; 31(6):754-6. PubMed ID: 25424217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of timolol, benzalkonium-preserved timolol, and benzalkonium-preserved brimonidine on oxidative stress biomarkers in the tear film.
    Sedlak L; Wojnar W; Zych M; Wyględowska-Promieńska D
    Cutan Ocul Toxicol; 2020 Sep; 39(3):260-268. PubMed ID: 32594785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial.
    Sherwood MB; Craven ER; Chou C; DuBiner HB; Batoosingh AL; Schiffman RM; Whitcup SM
    Arch Ophthalmol; 2006 Sep; 124(9):1230-8. PubMed ID: 16966616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
    Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA
    Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of ulcerated infantile hemangioma with brimonidine-timolol cream: 2 cases report and review of the literature.
    Almebayadh M
    J Dermatolog Treat; 2020 Jun; 31(4):433-434. PubMed ID: 30973791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A short term study of the additive effect of timolol and brimonidine on intraocular pressure.
    Arici MK; Sayici M; Toker M; Erdoğan H; Topalkara A
    Eye (Lond); 2002 Jan; 16(1):39-43. PubMed ID: 11913886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study.
    Katz LJ; Rauchman SH; Cottingham AJ; Simmons ST; Williams JM; Schiffman RM; Hollander DA
    Curr Med Res Opin; 2012 May; 28(5):781-8. PubMed ID: 22458918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phase III clinical trial of brimonidine in patients with primary open-angle glaucoma and ocular hypertension--comparison of the effects of brimonidine monotherapy versus timolol monotherapy, or combination brimonidine/prostaglandins therapy versus combination placebo/prostaglandins therapy].
    Araie M; Yamazaki Y; Sugiyama K; Kuwayama Y; Tanihara H
    Nippon Ganka Gakkai Zasshi; 2012 Oct; 116(10):955-66. PubMed ID: 23285843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of topical nipradilol and timolol maleate on intraocular pressure, facility of outflow, arterial blood pressure and pulse rate in dogs.
    Maehara S; Ono K; Ito N; Tsuzuki K; Seno T; Yokoyama T; Yamashita K; Izumisawa Y; Kotani T
    Vet Ophthalmol; 2004; 7(3):147-50. PubMed ID: 15091320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diadenosine tetraphosphate improves adrenergic anti-glaucomatous drug delivery and efficiency.
    Loma P; Guzman-Aranguez A; Perez de Lara MJ; Pintor J
    Exp Eye Res; 2015 May; 134():141-7. PubMed ID: 25701803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive effect of lacrimal occlusion on topical timolol-induced bronchoconstriction in asthmatics.
    Hepsen IF; Yildirim Z; Yilmaz H; Kotuk M
    Clin Exp Ophthalmol; 2004 Dec; 32(6):597-602. PubMed ID: 15575830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.2%.
    Katz G; Dubiner H; Samples J; Vold S; Sall K
    JAMA Ophthalmol; 2013 Jun; 131(6):724-30. PubMed ID: 23579344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel.
    Uusitalo H; Niño J; Tahvanainen K; Turjanmaa V; Ropo A; Tuominen J; Kähönen M
    Acta Ophthalmol Scand; 2005 Dec; 83(6):723-8. PubMed ID: 16396651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.